Restricting Antibiotic Use Fuels Drop in Antibiotic-resistant Infections
NOV 06, 2016 | CONTAGION EDITORIAL STAFF
Susan Kline, MD, MPH, associate professor of medicine, Division of Infectious Diseases and International Medicine, medical director for Infection Control, lead physician for Antibiotic Stewardship, University of Minnesota, discusses how restricting use of vancomycin impacted the emergence of vancomycin-resistant enterococci.
Interview Transcript (slightly modified for readability)
“Part of our goal is, if we see a lot of VRE, which is vancomycin-resistant enterococci, we want to reduce the selective pressure, [meaning] we want to minimize unnecessary vancomycin use. At our institution, vancomycin is a restricted antibiotic. It’s restricted to try to prevent further emergence of VRE. And so, we think because we have a tight restriction on vancomycin, that that’s part of the reason why we’ve actually seen a decrease of VRE infections during our intervention period, which has been going on [for] nearly 10 years.
Right now because we’re seeing more of a problem with carbapenem resistant enterobacteriaceae we’re starting to develop, we’re really trying to watch the use of the carbapenems, and trying to make sure that those aren’t being used unnecessarily, so that we don’t select for further carbapenem resistant enterobacteriaceae.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
Influenza A (H3N2) has caused most of the illnesses in this severe flu season, but influenza B is becoming increasingly responsible for more infections as the flu season continues to hit the United States.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512